The IMWG consists of 109 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects with a goal to improve myeloma treatment options and diagnostic systems.
The IMF Concise Review of the Disease and Treatment Options is an overview of myeloma, with a discussion of the pathophysiology, clinical features, and treatment options. It is hoped that the information will be helpful to health professionals and patients alike.
Production of a single, monoclonal protein (M-protein) is a characteristic feature of multiple myeloma. The test used to measure the amount of monoclonal protein in the blood or urine is protein electrophoresis.
These guidelines encompass both the published literature and expert opinions. Recommendations based upon expert opinions are identified as such. The intent is for the guidelines to be international in scope, plus provide recommendations for both clinical practice and research approaches. This article appeared in The Hematology Journal (2003) 4, 379-398.